Associated Papers
Hyperparathyroidism-Jaw Tumor Syndrome Associated to a CDC73 Gene Pathogenic VARIANT and a Nonossifying Desmoplastic Fibroma of the Mandible.
Elena C et al.
Case Reports in Endocrinology, 2025
Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid Tumorigenesis.
Pardi E et al.
The Journal of Clinical Endocrinology and Metabolism, 2024
The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y et al.
International Journal of Cancer, 2020
Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways.
Clarke CN et al.
Journal of the Endocrine Society, 2019
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L et al.
Human Mutation, 2017
Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.
Sun W et al.
Scientific Reports, 2017
29142233 (PubMed )
Supplement: 41598_2017_15715_MOESM1_ESM.pdf
Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
Newey PJ et al.
Human Mutation, 2010
HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach?
Silveira LG et al.
Arquivos Brasileiros De Endocrinologia E Metabologia, 2008
Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
Sarquis MS et al.
Surgery, 2008
Select a paper to view details